The consequences of waiting for cataract surgery: a systematic review
- PMID: 17452662
- PMCID: PMC1852875
- DOI: 10.1503/cmaj.060962
The consequences of waiting for cataract surgery: a systematic review
Abstract
Background: Cataract surgery is the most common operative procedure performed in Canada, and how patients are affected by wait times for this surgery has important clinical, public health and health policy considerations. We conducted a systematic review to understand the relation between wait time for cataract surgery and patient outcomes and the variables that modify this relation.
Methods: We performed an electronic search of 11 databases and the proceedings of 4 conferences. The search was restricted to studies published after the transition to phacoemulsification (1990). We assessed the quality of the included studies using the Jadad Scale for randomized controlled trials and the Newcastle-Ottawa Scale for cohort and case-control studies. The data were found to be inappropriate for meta-analysis, thus we performed a qualitative synthesis.
Results: We found a total of 27 studies that met our inclusion criteria. When these studies were reviewed, a dichotomy was observed for the wait time-outcome relation: outcomes associated with wait times of <or= 6 weeks were better than outcomes associated with wait times of >or= 6 months. Patients who waited more than 6 months to receive cataract surgery experienced more vision loss, a reduced quality of life and had an increased rate of falls compared with patients who had wait times of less than 6 weeks. The outcomes associated with wait times between 6 weeks and 6 months remain unclear.
Interpretation: Patients who wait more than 6 months for cataract surgery may experience negative outcomes during the wait period, including vision loss, a reduced quality of life and an increased rate of falls.
Figures
References
-
- Bell CM, Hatch WV, Cernat G, et al. Cataract surgery. In: Tu JV, Pinfold SP, McColgan P, et al., editors. Access to health services in Ontario: ICES atlas. Toronto: Institute for Clinical Evaluative Sciences; 2005. p. 71-90. Available: www.ices.on.ca/webpage.cfm?site_id=1&org_id=67&morg_id=0&gsec_id=0&item_... (accessed 2007 Feb 12).
-
- Klein BE, Klein R, Lee KE. Incidence of age-related cataract over a 10-year interval: the Beaver Dam Eye Study. Ophthalmology 2002;109:2052-7. - PubMed
-
- Moher D, Cook D, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999;354:1896-900. - PubMed
-
- Jadad A, Moore R, Carroll D, et al. Assessing the quality of report of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12. - PubMed
-
- Wells G, Shea B, O'Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Proceedings of the 3rd Symposium on Systematic Reviews. Beyond the basics: improving quality and impact; 2000 July 3-5; Oxford. Oxford, 2000.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous